Active substance
Ferrous sulfate
- SFDA 9
- NHS prices 3
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FEROMIN | 190 mg | Film-coated tablet · Oral use | 30 Bottle | SAR 15.60 | Generic · OTC | RIYADH PHARMA | Valid |
| FEROMIN ORAL DROPS | 125 mg/ml | Oral drops · Oral use | 1 Dropper Container | SAR 12.60 | Generic · Prescription | RIYADH PHARMA | Valid |
| HEMADID | 200 mg | Film-coated tablet · Oral use | 120 Bottle | SAR 63.15 | Generic · OTC | Jamjoom Pharmaceuticals Factory Company | Valid |
| KDIRON DROPS | 25 mg/ml | Drops · Oral use | 1 Dropper Container | SAR 8.40 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| FER-IN-SOL DROPS 15MG-0.6ML (ELEMENTAL I | 25 mg/ml | Oral drops · Oral use | 1 Bottle | SAR 18.30 | Generic · OTC | MEADJOHNSON | Withdrawn by regulatory authority · Not Marketed |
| FERROGRADUMET TABLET | 105 mg | Tablet · Oral use | 30 Blister | SAR 8.90 | NCE · OTC | Abbott Laboratories | Withdrawn by MAH · Not Marketed |
| FERTONIC DROPS 30ML | 125 mg | Oral drops · Oral use | 1 Bottle | SAR 7.35 | NCE · OTC | Ram Pharmaceutical Industries | Withdrawn by MAH · Not Marketed |
| JECTOFER AMP. 100 MG | 100 mg | Solution · Intravenous use | 10 Ampoule | SAR 39.75 | NCE · Prescription | AstraZeneca | Withdrawn by MAH · Not Marketed |
| KDIRON 200MG-5ML SYRUP | 40 mg/ml | Syrup · Oral use | 1 Bottle | SAR 4.65 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BARIATRIC SURGERY; IRON DEFICIENCY ANEMIA; MATERNAL AND CHILD HEALTHCARE- SUPPLEMENTATION FOR MOTHER AND CHILD
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Ferrous sulfate 125mg/ml oral drops sugar free | £30.00 | 15 ml | 1 Oct 2026 |
| NHS Drug Tariff | Ferrous sulfate 200mg tablets | £1.01 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ferrous sulfate 325mg modified-release tablets | £2.58 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- EMA PRAC 8 Jul 2016 PRAC signal: Mouth ulceration
Action for MAH: update of the product information: Yes - EMA PRAC 17 Mar 2016 PRAC signal: Mouth ulceration
Action for MAH: update of the product information: No
Combinations containing Ferrous sulfate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.